Loading...
uniQure N.V.
QURE•NASDAQ
Healthcare
Biotechnology
$22.82
$1.66(7.84%)
U.S. Market opens in 1h 49mQURE News Today: Stay Updated with the Latest uniQure N.V. News in Real Time
Find QURE news now at Meyka AI. Stay informed with the latest uniQure N.V. stocks updates, including price news, market analysis, and expert insights.
📅 in about 1 hour
QURE: H.C. Wainwright Maintains Buy, Cuts Price Target May 2026
H.C. Wainwright maintains Buy rating on QURE but lowers price target to $50 from $70, citing valuation adjustments.
Read more
📅 6 days ago
LOBE.CN stock surges 42% on April 30, 2026 as psychedelic biotech gains momentum
LOBE.CN stock jumps 42.1% to C$0.135 on April 30, 2026. Lobe Sciences Ltd. advances psilocybin therapeutics for PTSD and brain injuries.
Read more
📅 2 months ago
RBC Capital Downgrades uniQure N.V. (QURE) to Sector Perform Mar 2026
RBC and Cantor change views on uniQure; QURE analyst rating updates, implications, and price targets
Read more
📅 2 months ago
RBC Maintains Outperform on uniQure N.V. (QURE), Feb 2026
RBC maintains Outperform on uniQure; QURE analyst rating review and investor implications, Feb 2026
Read more